Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

proudly announces the latest release of PLANET ® Onco Dose version 3.2 – multi-radionuclide, personalized, voxel-based dosimetry platform for SIRT and MRT – now approved for market in EU ...

Wallabies Marika Koroibete and Samu Kerevi have added credit to their applications to play for Australia in this year's British & Irish Lions Test series with try-scoring doubles in Japan Rugby ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA ... and lost an additional 5.5% of their weight. “Based on prior studies on weight loss ...

001) Why it matters: The findings demonstrate that a family-based approach to lifestyle interventions can significantly improve weight management and cardiovascular health among high-risk individuals.

Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab has bought global rights to China-based United Laboratories International's (3933.HK), opens new tab so-called "triple-G" weight-loss drug ...

However, its producer Novo Nordisk uses the brand name Wegovy when it is sold as a weight-loss medication. Wegovy is also provided in larger doses to Ozempic. Clinical trials have shown that ...

CAS Key Laboratory of Quantum Information, University of Science and Technology of China, Hefei 230026 Anhui, China Institute of Artificial Intelligence, Hefei Comprehensive National Science Center, ...